Evidence map›Paper›PMID 22892566›Full record

ArticleThe EMBO journal2012

Upregulated function of mitochondria-associated ER membranes in Alzheimer disease.

Estela Area-Gomez, Maria Del Carmen Lara Castillo, Marc D Tambini, Cristina Guardia-Laguarta, Ad J C de Groof, Moneek Madra, Junichi Ikenouchi, Masato Umeda, Thomas D Bird, Stephen L Sturley and 1 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 369 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
369citing papers in PubMed, 1 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

369 citing papers in PubMed, 1 synthesis or guideline pooled it, 631 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Dysregulation of autophagosome-mitochondria contacts contributes to autophagy dysfunction and neurodegeneration in tauopathy.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

309 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Estela Area-GomezDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
Maria Del Carmen Lara Castillo
Marc D Tambini
Cristina Guardia-Laguarta
Ad J C de Groof
Moneek Madra
Junichi Ikenouchi
Masato Umeda
Thomas D Bird
Stephen L Sturley
Eric A Schon
Columbia University Irving Medical Center · USKyoto University · JPUniversity of Washington Medical Center · US

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
NIA NIH HHS AG005136NIA NIH HHS P50 AG005136
6 · The paper itself

Abstract

Alzheimer disease (AD) is associated with aberrant processing of the amyloid precursor protein (APP) by γ-secretase, via an unknown mechanism. We recently showed that presenilin-1 and -2, the catalytic components of γ-secretase, and γ-secretase activity itself, are highly enriched in a subcompartment of the endoplasmic reticulum (ER) that is physically and biochemically connected to mitochondria, called mitochondria-associated ER membranes (MAMs). We now show that MAM function and ER-mitochondrial communication-as measured by cholesteryl ester and phospholipid synthesis, respectively-are increased significantly in presenilin-mutant cells and in fibroblasts from patients with both the familial and sporadic forms of AD. We also show that MAM is an intracellular detergent-resistant lipid raft (LR)-like domain, consistent with the known presence of presenilins and γ-secretase activity in rafts. These findings may help explain not only the aberrant APP processing but also a number of other biochemical features of AD, including altered lipid metabolism and calcium homeostasis. We propose that upregulated MAM function at the ER-mitochondrial interface, and increased cross-talk between these two organelles, may play a hitherto unrecognized role in the pathogenesis of AD.

Indexed as

Alzheimer DiseaseAnimalsBlotting, WesternCells, CulturedEmbryo, MammalianEndoplasmic ReticulumFibroblastsHumansMembrane MicrodomainsMiceMice, KnockoutMitochondriaMitochondrial MembranesPresenilin-1Presenilin-2Real-Time Polymerase Chain ReactionPresenilin-1Presenilin-2RNA, MessengerRNA, Small Interfering

Identifiers

PMID22892566
PMCPMC3492725
OpenAlexW2166131107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.